Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index

NCT06706050 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ho-Yeon Song

Collaborators